ESCITALOPRAM

Generic: ESCITALOPRAM OXALATE

Jubilant Cadista Pharmaceuticals Inc.Manufacturer
ORALRoute
ESCITALOPRAM OXALATEActive Substance
2012-09-12Original Approval

ESCITALOPRAM is FDA application ANDA202280, sponsored by JUBILANT CADISTA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class III2016-03-24
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 2120

Labeling: Incorrect or Missing Lot and/or Expiration Date

Top Reported Reactions

1
DRUG INEFFECTIVE
4,822 reports
2
FATIGUE
4,607 reports
3
NAUSEA
4,375 reports
4
OFF LABEL USE
3,901 reports
5
HEADACHE
3,746 reports
6
DIARRHOEA
3,735 reports
7
DRUG INTERACTION
3,118 reports
8
DIZZINESS
3,098 reports
9
FALL
3,061 reports
10
ANXIETY
2,977 reports